IMJUDO
IMJUDO
Approved
DIN Number
02541009
Drug Class
Human
Market Date
Oct 23, 2023
Company
HC
astrazeneca canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02541009
AIG Number0164941001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01FX20 TREMELIMUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
TREMELIMUMABActive
Strength: 20 MG / ML
Monograph: TREMELIMUMAB